Ibn-Alhaytham Hospital Co (P.S.C) (ASE:IBNH)
Jordan · Delayed Price · Currency is JOD 0.8600
+0.0100 (1.18%)
At close: May 11, 2026
ASE:IBNH Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12.12 | 12.14 | 11.82 | 11.33 | 11.16 | 12.37 | |
Revenue Growth (YoY) | 5.32% | 2.73% | 4.27% | 1.52% | -9.72% | 11.61% |
Cost of Revenue | 7.66 | 7.84 | 7.65 | 9.02 | 8.08 | 8.61 |
Gross Profit | 4.46 | 4.3 | 4.17 | 2.32 | 3.08 | 3.76 |
Selling, General & Admin | 3.75 | 2.51 | 2.52 | 2.62 | 2.78 | 3.31 |
Other Operating Expenses | 0.03 | - | - | -0.23 | - | -0.18 |
Operating Expenses | 3.84 | 3.56 | 3.63 | 3.31 | 4.61 | 4.35 |
Operating Income | 0.63 | 0.74 | 0.54 | -1 | -1.52 | -0.59 |
Interest Expense | -0.89 | -0.82 | -0.8 | -0.68 | -0.19 | -0.11 |
Interest & Investment Income | - | - | - | 0.14 | 0.14 | 0.11 |
Earnings From Equity Investments | 0 | 0.01 | -0.03 | 0.01 | -0.01 | 0.01 |
Other Non Operating Income (Expenses) | 0.45 | 0.3 | 0.28 | -0.6 | 0.24 | - |
EBT Excluding Unusual Items | 0.19 | 0.24 | -0.01 | -2.13 | -1.35 | -0.58 |
Gain (Loss) on Sale of Investments | - | 0.14 | 0.11 | - | - | - |
Legal Settlements | - | -0 | -0.01 | -0.4 | -1.32 | - |
Other Unusual Items | - | -0 | - | - | - | - |
Pretax Income | 0.19 | 0.38 | 0.1 | -2.53 | -2.66 | -0.58 |
Income Tax Expense | 0.05 | 0.05 | - | - | - | - |
Net Income | 0.14 | 0.32 | 0.1 | -2.53 | -2.66 | -0.58 |
Net Income to Common | 0.14 | 0.32 | 0.1 | -2.53 | -2.66 | -0.58 |
Net Income Growth | - | 237.96% | - | - | - | - |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 |
EPS (Basic) | 0.01 | 0.02 | 0.00 | -0.13 | -0.13 | -0.03 |
EPS (Diluted) | 0.01 | 0.02 | 0.00 | -0.13 | -0.13 | -0.03 |
EPS Growth | - | 237.99% | - | - | - | - |
Free Cash Flow | - | -0.59 | 0.32 | -3.62 | -2.2 | 0.42 |
Free Cash Flow Per Share | - | -0.03 | 0.02 | -0.18 | -0.11 | 0.02 |
Gross Margin | 36.80% | 35.43% | 35.28% | 20.43% | 27.62% | 30.39% |
Operating Margin | 5.17% | 6.13% | 4.55% | -8.80% | -13.63% | -4.76% |
Profit Margin | 1.16% | 2.66% | 0.81% | -22.30% | -23.85% | -4.70% |
Free Cash Flow Margin | - | -4.88% | 2.69% | -31.94% | -19.73% | 3.39% |
EBITDA | 1.72 | 1.79 | 1.65 | 0.61 | 0.56 | 1.48 |
EBITDA Margin | 14.19% | 14.72% | 13.98% | 5.37% | 5.02% | 11.98% |
D&A For EBITDA | 1.09 | 1.04 | 1.11 | 1.61 | 2.08 | 2.07 |
EBIT | 0.63 | 0.74 | 0.54 | -1 | -1.52 | -0.59 |
EBIT Margin | 5.17% | 6.13% | 4.55% | -8.80% | -13.63% | -4.76% |
Effective Tax Rate | 27.12% | 14.13% | - | - | - | - |
Advertising Expenses | - | - | - | 0 | 0 | 0.01 |